Fortress Biotech, Inc.
FBIO
$3.86
$0.277.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 63.80% | 24.49% | 24.14% | 38.05% | 57.51% |
| Total Depreciation and Amortization | -7.05% | -6.04% | -25.56% | -33.90% | -36.22% |
| Total Amortization of Deferred Charges | -43.28% | -41.94% | -32.26% | -26.77% | -15.27% |
| Total Other Non-Cash Items | -20.22% | 53.89% | 48.06% | 48.80% | 56.36% |
| Change in Net Operating Assets | 12.38% | -23.56% | 40.75% | -398.45% | -258.67% |
| Cash from Operations | 19.05% | 32.63% | 37.46% | 27.57% | 40.98% |
| Capital Expenditure | -- | -- | -- | 77.78% | 97.38% |
| Sale of Property, Plant, and Equipment | -80.58% | -80.58% | -- | -100.00% | 4,624.41% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,349.28% | -393.42% | -86.57% | 99.58% | 85.91% |
| Cash from Investing | -256.99% | -577.56% | -613.27% | 97.41% | 159.31% |
| Total Debt Issued | 98.01% | 200.57% | 2.68% | 61.20% | -48.61% |
| Total Debt Repaid | 82.81% | 96.55% | 98.48% | 99.38% | 85.73% |
| Issuance of Common Stock | -56.00% | -45.17% | -10.38% | 89.96% | 53.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 33.75% | 62.50% | -- | -370.59% | -370.59% |
| Total Dividends Paid | 100.00% | 75.00% | 50.00% | 24.99% | -0.01% |
| Other Financing Activities | -35.37% | -33.14% | -82.17% | -78.59% | 30.52% |
| Cash from Financing | 2.56% | 147.13% | 115.77% | 1,042.95% | 486.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.72% | 109.73% | 74.84% | 89.82% | 93.23% |